144 related articles for article (PubMed ID: 9135084)
1. A membrane cofactor protein transgenic mouse model for the study of discordant xenograft rejection.
Yannoutsos N; Ijzermans JN; Harkes C; Bonthuis F; Zhou CY; White D; Marquet RL; Grosveld F
Genes Cells; 1996 Apr; 1(4):409-19. PubMed ID: 9135084
[TBL] [Abstract][Full Text] [Related]
2. A human CD46 transgenic pig model system for the study of discordant xenotransplantation.
Diamond LE; Quinn CM; Martin MJ; Lawson J; Platt JL; Logan JS
Transplantation; 2001 Jan; 71(1):132-42. PubMed ID: 11211178
[TBL] [Abstract][Full Text] [Related]
3. An in vivo model of hyperacute rejection: characterization and evaluation of the effect of transgenic human complement inhibitors.
Mora M; Lazzer M; Marsicano G; Mulder LC; Carraresi L; Pieri A; Benanchi A; Grifoni D; Nuti S; Bruzzone P; Comporti M; Cortesini R; Rossini M
Transgenic Res; 2000 Jun; 9(3):205-13. PubMed ID: 11032369
[TBL] [Abstract][Full Text] [Related]
4. Relative roles of hCD46 and hCD55 in the regulation of hyperacute rejection.
Verbakel CA; Bonthuis F; Eerhart SE; van Dixhoorn M; Grosveld F; Marquet RL; IJzermans JN
Transplant Proc; 2000 Aug; 32(5):903-4. PubMed ID: 10936266
[No Abstract] [Full Text] [Related]
5. Kidneys derived from mice transgenic for human complement blockers are protected in an in vivo model of hyperacute rejection.
Lazzeri M; Mora M; Mulder LC; Marsicano G; Marinucci G; Boschi M; Bruzzone P; Alfani D; Cortesini R; Rossini M
J Urol; 1998 Apr; 159(4):1364-9. PubMed ID: 9507885
[TBL] [Abstract][Full Text] [Related]
6. Expression of a functional human complement inhibitor in a transgenic pig as a model for the prevention of xenogeneic hyperacute organ rejection.
Fodor WL; Williams BL; Matis LA; Madri JA; Rollins SA; Knight JW; Velander W; Squinto SP
Proc Natl Acad Sci U S A; 1994 Nov; 91(23):11153-7. PubMed ID: 7526391
[TBL] [Abstract][Full Text] [Related]
7. Tissue expression of human decay accelerating factor, a regulator of complement activation expressed in mice: a potential approach to inhibition of hyperacute xenograft rejection.
Cary N; Moody J; Yannoutsos N; Wallwork J; White D
Transplant Proc; 1993 Feb; 25(1 Pt 1):400-1. PubMed ID: 7679815
[No Abstract] [Full Text] [Related]
8. Expression and functional analysis of glycosyl-phosphatidyl inositol-linked CD46 in transgenic mice.
Shinkel TA; Cowan PJ; Barlow H; Aminian A; Romanella M; Lublin DM; Pearse MJ; d'Apice AJ
Transplantation; 1998 Dec; 66(11):1401-6. PubMed ID: 9869079
[TBL] [Abstract][Full Text] [Related]
9. Molecular remodelling of human CD46 for xenotransplantation: designing a potent complement regulator without measles virus receptor activity.
Begum NA; Murakami Y; Mikata S; Matsumoto M; Hatanaka M; Nagasawa S; Kinoshita T; Seya T
Immunology; 2000 May; 100(1):131-9. PubMed ID: 10809968
[TBL] [Abstract][Full Text] [Related]
10. Human CD46 but not CD59 in transgenic mice protects against hyperacute rejection evoked by ex vivo perfusion with human serum.
Marquet RL; van Stijn I; van den Tol PM; Bonthuis F; Yannoutsos N; IJzermans JN
Transplant Proc; 1997; 29(1-2):931-2. PubMed ID: 9123592
[No Abstract] [Full Text] [Related]
11. Coagulation cascade activation triggers early failure of pig hearts expressing human complement regulatory genes.
Wu G; Pfeiffer S; Schröder C; Zhang T; Nguyen BN; Kelishadi S; Atkinson JB; Schuurman HJ; White DJ; Azimzadeh AM; Pierson RN
Xenotransplantation; 2007 Jan; 14(1):34-47. PubMed ID: 17214703
[TBL] [Abstract][Full Text] [Related]
12. Transgenic expression of a CD46 (membrane cofactor protein) minigene: studies of xenotransplantation and measles virus infection.
Thorley BR; Milland J; Christiansen D; Lanteri MB; McInnes B; Moeller I; Rivailler P; Horvat B; Rabourdin-Combe C; Gerlier D; McKenzie IF; Loveland BE
Eur J Immunol; 1997 Mar; 27(3):726-34. PubMed ID: 9079815
[TBL] [Abstract][Full Text] [Related]
13. Transgenic expression of human complement regulatory proteins in mice results in diminished complement deposition during organ xenoperfusion.
McCurry KR; Kooyman DL; Diamond LE; Byrne GW; Logan JS; Platt JL
Transplantation; 1995 Apr; 59(8):1177-82. PubMed ID: 7537395
[TBL] [Abstract][Full Text] [Related]
14. Transplantation of MCP cardiac xenografts into baboon recipients.
Kadner A; Chen RH; Farivar RS; Santerre D; Adams DH
Transplant Proc; 2001; 33(1-2):770-2. PubMed ID: 11267062
[No Abstract] [Full Text] [Related]
15. The pig analogue of CD59 protects transgenic mouse hearts from injury by human complement.
Fisicaro N; Aminian A; Hinchliffe SJ; Morgan BP; Pearse MJ; D'Apice AJ; Cowan PJ
Transplantation; 2000 Sep; 70(6):963-8. PubMed ID: 11014650
[TBL] [Abstract][Full Text] [Related]
16. A recombinant soluble chimeric complement inhibitor composed of human CD46 and CD55 reduces acute cardiac tissue injury in models of pig-to-human heart transplantation.
Kroshus TJ; Salerno CT; Yeh CG; Higgins PJ; Bolman RM; Dalmasso AP
Transplantation; 2000 Jun; 69(11):2282-9. PubMed ID: 10868627
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of hyperacute transplant rejection by soluble proteins with the functional domains of CD46 and FcgammaRII.
Lanteri MB; Powell MS; Christiansen D; Li YQ; Hogarth M; Sandrin MS; Mckenzie IF; Loveland BE
Transplantation; 2000 Mar; 69(6):1128-36. PubMed ID: 10762218
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a CD46 transgenic pig and protection of transgenic kidneys against hyperacute rejection in non-immunosuppressed baboons.
Loveland BE; Milland J; Kyriakou P; Thorley BR; Christiansen D; Lanteri MB; Regensburg M; Duffield M; French AJ; Williams L; Baker L; Brandon MR; Xing PX; Kahn D; McKenzie IF
Xenotransplantation; 2004 Mar; 11(2):171-83. PubMed ID: 14962279
[TBL] [Abstract][Full Text] [Related]
19. Human membrane cofactor protein (MCP, CD 46) protects transgenic pig hearts from hyperacute rejection in primates.
Adams DH; Kadner A; Chen RH; Farivar RS
Xenotransplantation; 2001 Feb; 8(1):36-40. PubMed ID: 11208189
[TBL] [Abstract][Full Text] [Related]
20. Transgenic expression in pig hearts of both human decay-accelerating factor and human membrane cofactor protein does not provide an additional benefit to that of human decay-accelerating factor alone in pig-to-baboon xenotransplantation.
Mañez R; Lopez-Pelaez E; Centeno A; Herrera JM; Juffe A; Domenech N; Harrison R; Schuurman HJ
Transplantation; 2004 Sep; 78(6):930-3. PubMed ID: 15385816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
